Treatment
Insulin clinical trials
We’re tracking 345 recruiting studies that include Insulin, each written for real people, not researchers, below.
Recruiting studies
- NCT03742011Recruiting
Study of babies born to mothers with PCOS in Guangzhou
This study looks at children born to mothers who have polycystic ovary syndrome (PCOS). It aims to learn about their health by following families in Guangzhou over time.
Guangzhou, GuangdongAges Up to 18 years - NCT06193668Recruiting
Overfeeding and fat tissue stimulation study
This trial looks at how overfeeding affects fat tissue in healthy, inactive young adults. You may help researchers understand weight gain and metabolism.
Düsseldorf, North Rhine-WestphaliaAges 18–40 - NCT07861191Recruiting
Using continuous glucose monitors to improve insulin sensitivity
This study tests whether using a continuous glucose monitor (CGM) helps people without diabetes improve their insulin sensitivity. You would wear a small sensor that tracks your glucose levels in real time, and the study may help you understand how your body responds to food and activity.
Singapore, SingaporeAges 21–70 - NCT06469593Recruiting
Automated insulin delivery for type 1 diabetes study
This study tests a new automated insulin delivery (AID) system that connects your insulin pump to your glucose monitor to help keep your blood sugar in range. It is for both children and adults with type 1 diabetes who have not used an AID system before.
Herlev, Greater CopenhagenAges 7 years+ - NCT07801001Enrolling by invitation
Zinc supplements for women with polycystic ovary syndrome
This study tests whether taking zinc supplements can improve insulin resistance and reduce symptoms in women with polycystic ovary syndrome (PCOS). If you have PCOS and are not pregnant, you may be able to join.
DhakaAges 18–45 - NCT07802262Recruiting
Prenatal exercise and blood sugar regulation
This trial tests whether a supervised exercise program during weeks 24 to 30 of pregnancy helps regulate blood sugar levels. It may help support a healthier pregnancy by improving glucose control.
Conway, ArkansasAges 18–35 - NCT07778524RecruitingPhase 1
Alpelisib challenge test for body weight study
This study tests a single dose of a drug called alpelisib to see how it affects body weight and metabolism. It may help researchers understand how the drug could be used for weight-related conditions.
New York, New YorkAges 18–70 - NCT07773779Recruiting
App and nutrition support for blood sugar control
This study tests a smartphone app combined with dietary guidance to help adults with type 1 or type 2 diabetes improve their blood sugar levels. Participants will use the app with their continuous glucose monitor to track meals and get personalized support, with the goal of better glycemic control and quality of life.
New York, New YorkAges 18–75 - NCT07724522Recruiting
Prebiotic Fiber for Irregular Periods in Women
This study tests whether taking a prebiotic fiber (inulin) can help women who are in the later years of their reproductive life (before menopause) and have irregular periods. You may be eligible if you are overweight, have irregular cycles, sit a lot, and do not exercise much.
Washington D.C., District of ColumbiaAges 40–55 - NCT07710274Recruiting
Personalized Program for Insulin Resistance in Metabolic Syndrome
This pilot study tests a personalized program called PRISM to help improve how your body responds to insulin. If you have metabolic syndrome (a cluster of conditions like large waist size, high blood pressure, or high blood sugar) and insulin resistance, the study will use a continuous glucose monitor, smart ring, and food logging app to give you tailored feedback.
SingaporeAges 21–70 - NCT07699380RecruitingPhase 2
Metabolic therapy to improve insulin sensitivity in type 1 diabetes
This trial tests a drug that may help your body use insulin better and improve how your cells produce energy. It might lead to better blood sugar control and less insulin needed.
Seattle, WashingtonAges 18–69 - NCT07703371Recruiting
Kodo millet porridge and its effect on gut health and metabolic syndrome
This study tests whether eating Kodo millet porridge every day for 12 weeks can improve gut health and reduce risk factors for metabolic syndrome (like being overweight). If you are between 20 and 60 years old, are overweight or obese, and are willing to eat the porridge daily without changing your diet or exercise, you may be able to join.
Mysore, KarnatakaAges 20–60 - NCT05760339Recruiting
Intermittent fasting vs carbohydrate drinks before elective surgery
This study compares two ways of eating before planned (elective) orthopedic surgery: intermittent fasting versus carbohydrate drinks. It aims to see which approach is safer and works better around the time of surgery.
Amsterdam, North HollandAges 18 years+ - NCT07690163Recruiting
Diabetes blood sugar check in newly diagnosed patients
This trial is checking how well blood sugar is controlled in adults recently diagnosed with type 2 diabetes (within the last 3 months). It aims to see if current treatments or lifestyle changes are working and may help guide future care.
KyivAges 18 years+ - NCT07685015Recruiting
Myo-Inositol for blood sugar control in gestational diabetes
This trial tests if a natural supplement called myo-inositol can help manage blood sugar and reduce stress on your body during pregnancy while you have gestational diabetes.
Vienna, State of ViennaAges 18–45 - NCT07664553RecruitingPhase 3
Testing a new diabetes tablet for people on insulin
This trial tests a new once-daily tablet (elecoglipron) against a placebo to see if it can help improve blood sugar control in adults with type 2 diabetes who are already on insulin. It may offer an additional treatment option to help manage your diabetes.
Little Rock, ArkansasAges 18 years+ - NCT07655076RecruitingEarly Phase 1
Smart insulin delivery study for type 1 diabetes
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
Toronto, OntarioAges 18 years+ - NCT06585982Recruiting
Synbiotics for MAFLD: gut health and liver fat study
This trial tests whether taking a synbiotic (a mix of helpful bacteria and fiber) can improve insulin levels and reduce inflammation in people with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD). It may help by changing the balance of bacteria in your gut.
Semarang, SemarangAges 25–55 - NCT07635576Recruiting
How Stomach Stimulation Affects Insulin Levels
This study looks at how a surgically implanted device that stimulates the stomach (called a GES device) affects your body's insulin levels. Researchers will collect blood samples over several hours to understand if and how the device influences insulin production.
Indianapolis, IndianaAges 18 years+ - NCT07624500Recruiting
How Different Foods Affect Your Metabolism and Blood Sugar
This study tests how specific foods impact your body's ability to manage blood sugar and fat levels. You'll eat meals provided by the research team for about 12 weeks to help researchers understand which foods work best for people with high triglycerides (a type of blood fat) and insulin resistance (difficulty managing blood sugar).
Chicago, IllinoisAges 40–70 - NCT07621445Recruiting
Understanding Genetic Risk in Recently Diagnosed Diabetes
This study looks at genetic factors in people recently diagnosed with diabetes to understand what might predict who needs insulin treatment. Researchers will analyze blood samples and medical information to see if genetic testing could help doctors predict your treatment path.
Changsha, HunanAges 14–50 - NCT06419777Recruiting
When to start diabetes medicine in pregnancy
This study compares two ways of starting diabetes medication during pregnancy for women with gestational diabetes. It will test whether starting medication earlier or later helps control blood sugar and leads to better outcomes for you and your baby.
Rochester, New YorkAges 18 years+ - NCT06419803Recruiting
When to start medication for gestational diabetes
This study compares two different blood sugar targets to decide when to start medication for gestational diabetes. It aims to find the safest approach for you and your baby.
Rochester, New YorkAges 18 years+ - NCT06360302Recruiting
Exercise and insulin resistance in dialysis patients
This study looks at how exercise affects muscle metabolism and insulin resistance in people on dialysis, compared to those with metabolic syndrome and healthy individuals. It aims to find blood markers that could help assess insulin resistance in dialysis patients.
MontpellierAges 40–75
Common questions
- Are there clinical trials studying Insulin?
- Yes. Clin2 currently lists 345 recruiting studies that include Insulin, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Insulin trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Insulin an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Insulin or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.